OR WAIT null SECS
November 02, 2023
Re-evaluating the basics of mAb production may be beneficial for the biopharma industry as a whole.
September 01, 2023
Process and bioreactor performance are directly impacted by real-time monitoring capabilities.
August 22, 2023
Sartorius’ Biostat STR now incorporates Repligen’s XCell ATF hardware.
August 02, 2023
Scale-up strategies for cell culture will require a deep understanding of overall bioprocess workflows.
July 27, 2023
MilliporeSigma has invested $25 million to expand its cell culture media production facility in Lenexa, Kan.
July 02, 2023
The choice of expression system requires wise consideration of product complexities.
June 15, 2023
The bioreactor scaler tool helps scaling between development and manufacturing and to de-risk scaling activities and ensure product quality.
April 02, 2023
The innovation of going from stainless-steel bioreactors to fixed-bed bioreactors shows an evolution in upstream optimization.
October 12, 2022
Using a predictive modeling approach can help tighten up operator control over bioprocessing, which in turn can increase bioreactor output.
October 10, 2022
Cytiva’s acquisition of CEVEC Pharmaceuticals strengthens the company’s cell line development and biomanufacturing capabilities.
